Table I.
Characteristics | Cases (n=100) | Controls (n=100) |
---|---|---|
Age (mean ± SD)a | 69.99±8.59 | 66.91±11.89 |
PSA (ng/ml) | ||
<10 | 25 | |
10–20 | 35 | |
>20 | 40 | |
Gleason score | ||
≤6 | 24 | |
7 | 46 | |
≥8 | 30 | |
pT stage | ||
≤T2a | 54 | |
T2b | 33 | |
≥T2c | 13 |
Cases vs. controls, P>0.05. SD, standard deviation; PSA, prostate-specific antigen.